Christian Heiss: A Practical Synthesis on Peripheral Artery Disease in the Legs
Christian Heiss, Associate Head of Medical School (Research and Innovation) at the University of Surrey, Professor and NHS Consultant in Interventional Cardiovascular Medicine, shared a post on LinkedIn:
”New NEJM Clinical Practice review on PAD in the legs (McDermott).
A really practical synthesis that reinforces a few key points:
- PAD remains common and functionally limiting, with diagnosis still anchored around ABI <0.90. My take: Using quantitative Doppler waveform analysis.
- Event prevention is ‘full-spectrum’: intensive lipid-lowering (statins), antiplatelet therapy / low-dose aspirin + rivaroxaban (where appropriate), BP <130/80, and in relevant patients GLP-1RA (semaglutide) and SGLT2 inhibitors.
- For symptoms, supervised or structured home-based walking exercise remains foundational; revascularisation is best reserved for persistent symptoms not responding to exercise.
- Worth a read for anyone building PAD pathways across primary care/CDC and vascular services.”
Title: Peripheral Artery Disease in the Legs
Author: Mary M. McDermott
Read the Full Article on NEJM Clinical Practice

Title: Prognostic and predictive value of ultrasound-based estimated ankle brachial pressure index at early follow-up after endovascular revascularization of chronic limb-threatening ischaemia: a prospective, single-centre, service evaluation
Authors: Alexander D Rodway, Lydia Hanna, Jenny Harris, Rachael Jarrett, Charlotte Allan, Felipe Pazos Casal, Benjamin C T Field, Martin B Whyte, Nikolaos Ntagiantas, Ivan Walton, Ajay Pankhania, Simon S Skene, Gary D Maytham, Christian Heiss
Read the Full Article on eClinicalMedicine

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines